FDA approves Biogen's drug for rare form of ALS

ViewThe U.S. Food and Drug Administration has approved a new drug to treat a rare form of Amyotrophic Lateral Sclerosis (ALS), also commonly known as Lou Gehrig’s disease.

The injectable drug can now be used for patients with a very specific mutation which affects fewer than 500 people with ALS in the United States.

The...